Document is current
Any future updates will be listed below
-
Authors
Besson, Juliette
Audran, Régine
Karlen, Maxime
Miauton, Alix
Hajjami, Hélène Maby-El
Warpelin-Decrausaz, Loane
Sene, Loredana
Schaufelberger, Sylvain
Faivre, Vincent
Faouzi, Mohamed
Hartley, Mary-Anne
Spertini, François
Genton, Blaise
-
Funding
Funding for this research was provided by:
Emergex Vaccines Holding Limited
University of Lausanne
- License Information
-
More Information
Article History
Received: 21 October 2024
Accepted: 21 March 2025
First Online: 7 April 2025
Declarations
:
: This study adhered to the Declaration of Helsinki and was approved by the local Ethics Committee (Commission cantonale d'éthique de la recherche sur l'être humain, CER-VD, CER-VD, 2021–014626, approved 19.07.2021) and the Swiss regulatory authority (Swissmedic, 2021DR1042, approved 24.09.2021). All participants provided written informed consent. This study is registered at ClinicalTrials.gov (NCT05113862, approved 09.11.2021).
: Not applicable.
: The authors declare no competing interests.
